C07C 223/00
Compounds containing amino and —cho groups bound to the same carbon skeleton
Official title: Compounds containing amino and —CHO groups bound to the same carbon skeleton
C07C223/00 (Compounds containing amino and —cho groups bound to the same carbon skeleton) appears on 120 US grants and 108 published applications in this corpus.
Search patents in C07C- Granted patents
- 120
- Published applications
- 108
- Assignees
- 103
- Inventors
- 335
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 0 | 2 |
| 2003 | 2 | 1 |
| 2004 | 1 | 5 |
| 2005 | 2 | 3 |
| 2006 | 3 | 2 |
| 2007 | 2 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 4 |
| 2010 | 1 | 1 |
| 2011 | 0 | 8 |
| 2012 | 1 | 3 |
| 2013 | 6 | 7 |
| 2014 | 6 | 9 |
| 2015 | 5 | 8 |
| 2016 | 5 | 7 |
| 2017 | 8 | 8 |
| 2018 | 12 | 12 |
| 2019 | 4 | 5 |
| 2020 | 7 | 7 |
| 2021 | 2 | 6 |
| 2022 | 6 | 5 |
| 2023 | 5 | 1 |
| 2024 | 1 | 0 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound, and composition for forming hole transporting layer for perovskite solar cells15 Sep 2026US 12,735,395 B2Tokyo Chemical Industry Co., Ltd.
- 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors4 Nov 2025US 12,459,906 B2Dr. Falk Pharma GmbH
- Substituted piperazines as disrupters of AB42 oligomer formation27 May 2025US 12,312,296 B2Acelot, Inc.
- PEG lipids and uses thereof26 Nov 2024US 12,151,029 B2ModernaTX, Inc.
- Substituted amines as disrupters of ABETA42 oligomer formation28 Nov 2023US 11,827,582 B2Acelot, Inc.
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Peg lipids and uses thereof15 May 2025US 2025/0152518 A1ModernaTX, Inc.
- Hexavalent substituted benzenes8 May 2025US 2025/0145767 A1Northeastern University
- Small Molecule Drugs and Related Methods for Treatment of Diseases Related to Abeta42 Oligomer Formation19 Oct 2023US 2023/0331658 A1Acelot, Inc.
- Compounds as modulators of tlr2 signaling15 Dec 2022US 2022/0396583 A1Neuropore Therapies, Inc.
Most cited
By later US patents
- Therapeutically useful 2-aminotetralin derivatives36US 6,331,636 B1The Upjohn Company · 2001
- Therapeutically useful 2-aminotetralin derivatives33US 5,545,755 AThe Upjohn Company · 1996
- Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom32US 5,087,743 ABASF SE · 1992
- 2-aminoindans as selective dopamine D3 ligands32US 5,708,018 APharmacia & Upjohn Company · 1998
- N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents28US 4,981,865 AWarner-Lambert Company · 1991